September 17th, 2021 · Common Contracts · 1000 similar Endurance Acquisition Corp. – INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of September 14, 2021 by and between Endurance Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
This Investment Management Trust Agreement (this “Agreement”) is made effective as of September 14, 2021 by and between Endurance Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
June 10th, 2020 · Common Contracts · 1000 similar Ekso Bionics Holdings, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of June 7, 2020, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of June 7, 2020, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
January 29th, 2021 · Common Contracts · 1000 similar Science Strategic Acquisition Corp. Alpha – 27,000,000 Units Science Strategic Acquisition Corp. Alpha UNDERWRITING AGREEMENT
August 23rd, 2017 · Common Contracts · 1000 similar Mantech International Corp – SECOND AMENDED AND RESTATED CREDIT AGREEMENT This SECOND AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of August 17, 2017, among MANTECH INTERNATIONAL CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer and PNC BANK, NATIONAL ASSOCIATION as Swing Line Lender.
This SECOND AMENDED AND RESTATED CREDIT AGREEMENT (“Agreement”) is entered into as of August 17, 2017, among MANTECH INTERNATIONAL CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent and L/C Issuer and PNC BANK, NATIONAL ASSOCIATION as Swing Line Lender.
May 28th, 2021 · Common Contracts · 990 similar Jones Lang LaSalle Income Property Trust, Inc. – SECOND AMENDED AND RESTATED CREDIT AGREEMENT, dated as of May 24, 2021, among JONES LANG LASALLE INCOME PROPERTY TRUST, INC. and JLLIPT HOLDINGS LP, as Borrowers, The LENDERS Party Hereto, JPMORGAN CHASE BANK, N.A. as Administrative Agent, JPMORGAN... SCHEDULE I - Commitments SCHEDULE II - Initial Guarantors SCHEDULE III - Subsidiaries SCHEDULE IV - List of Funding Agreements and Other Credit Agreements
SCHEDULE I - Commitments SCHEDULE II - Initial Guarantors SCHEDULE III - Subsidiaries SCHEDULE IV - List of Funding Agreements and Other Credit Agreements
August 13th, 2021 · Common Contracts · 914 similar BrightSpire Capital, Inc. – BRIGHTSPIRE CAPITAL, INC. (a Maryland corporation) 8,250,000 Shares of Class A Common Stock UNDERWRITING AGREEMENT Dated: August 10, 2021 The undersigned, a stockholder [and an officer and/or director] of BrightSpire Capital, Inc., a Maryland corporation (the “Company”), understands that BofA Securities, Inc. (“BofA”) and J.P. Morgan Securities LLC propose(s) to enter into an Underwriting Agreement (the “Underwriting Agreement”) with the Company and the Selling Stockholder providing for the public offering of shares of the Company’s Class A common stock, par value $0.01 per share (the “Common Stock”). In recognition of the benefit that such an offering will confer upon the undersigned as a stockholder [and an officer and/or director] of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each underwriter to be named in the Underwriting Agreement that, during the period beginning on the date hereof and ending on the date that is 60 days from the date of the Underwriting Agreement (the “Expiration Date”) (subject to extensions
The undersigned, a stockholder [and an officer and/or director] of BrightSpire Capital, Inc., a Maryland corporation (the “Company”), understands that BofA Securities, Inc. (“BofA”) and J.P. Morgan Securities LLC propose(s) to enter into an Underwriting Agreement (the “Underwriting Agreement”) with the Company and the Selling Stockholder providing for the public offering of shares of the Company’s Class A common stock, par value $0.01 per share (the “Common Stock”). In recognition of the benefit that such an offering will confer upon the undersigned as a stockholder [and an officer and/or director] of the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each underwriter to be named in the Underwriting Agreement that, during the period beginning on the date hereof and ending on the date that is 60 days from the date of the Underwriting Agreement (the “Expiration Date”) (subject to extensions
September 17th, 2021 · Common Contracts · 876 similar Endurance Acquisition Corp. – UNDERWRITING AGREEMENT between ENDURANCE ACQUISITION CORP. and CANTOR FITZGERALD & CO. Dated: September 14, 2021 ENDURANCE ACQUISITION CORP. UNDERWRITING AGREEMENT The undersigned, Endurance Acquisition Corp., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with Cantor Fitzgerald & Co. (“Cantor Fitzgerald” or the “Representative”) and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the “Underwriters” or, each underwriter individually, an “Underwriter,” provided that if only Cantor Fitzgerald is listed on such Schedule A, any references to Underwriters shall refer exclusively to Cantor Fitzgerald)) as follows:
The undersigned, Endurance Acquisition Corp., a Cayman Islands exempted company (the “Company”), hereby confirms its agreement with Cantor Fitzgerald & Co. (“Cantor Fitzgerald” or the “Representative”) and with the other underwriters named on Schedule A hereto (if any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred to herein as the “Underwriters” or, each underwriter individually, an “Underwriter,” provided that if only Cantor Fitzgerald is listed on such Schedule A, any references to Underwriters shall refer exclusively to Cantor Fitzgerald)) as follows:
April 5th, 2017 · Common Contracts · 791 similar BioLineRx Ltd. – UNDERWRITING AGREEMENT between BIOLINERX LTD. and JMP SECURITIES LLC, as Representative of the Several Underwriters BIOLINERX LTD. UNDERWRITING AGREEMENT The undersigned, BioLineRx Ltd., a corporation formed under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BioLineRx Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with JMP Securities LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
The undersigned, BioLineRx Ltd., a corporation formed under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of BioLineRx Ltd., the “Company”), hereby confirms its agreement (this “Agreement”) with JMP Securities LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
February 11th, 2021 · Common Contracts · 627 similar Ekso Bionics Holdings, Inc. – Ekso Bionics Holdings, Inc. 3,902,440 Shares of Common Stock (par value $0.001 per share) Amended and Restated Underwriting Agreement Ekso Bionics Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 3,902,440 shares of its common stock, par value $0.001 per share (the “Shares”). The 3,902,440 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 585,366 Shares as provided in Section 2 (the “Optional Shares”). The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” H.C. Wainwright & Co., LLC (“Wainwright”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as used herein
Ekso Bionics Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 3,902,440 shares of its common stock, par value $0.001 per share (the “Shares”). The 3,902,440 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 585,366 Shares as provided in Section 2 (the “Optional Shares”). The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” H.C. Wainwright & Co., LLC (“Wainwright”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as used herein
July 15th, 2010 · Common Contracts · 599 similar Biomimetic Therapeutics, Inc. – BIOMIMETIC THERAPEUTICS, INC. 5,000,000 Shares of Common Stock Underwriting Agreement BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 5,000,000 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 750,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 5,000,000 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 750,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
July 10th, 2008 · Common Contracts · 532 similar QPC Lasers – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July 8, 2008 by and among QPC Lasers, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of July 8, 2008 by and among QPC Lasers, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
July 8th, 2004 · Common Contracts · 523 similar Central Credit, LLC – GLOBAL CASH ACCESS, L.L.C. and GLOBAL CASH ACCESS FINANCE CORPORATION, as Issuers, CCI ACQUISITION, LLC and CENTRAL CREDIT, LLC, as Subsidiary Guarantors, and THE BANK OF NEW YORK, as Trustee INDENTURE dated as of March 10, 2004 among Global Cash Access, L.L.C., a Delaware limited liability company (the “Company”), Global Cash Access Finance Corporation, a Delaware corporation (“Finance Corp.” and, together with the Company, the “Co-Obligors”), the Subsidiary Guarantors (as defined below) and The Bank of New York, a New York banking corporation, as Trustee.
INDENTURE dated as of March 10, 2004 among Global Cash Access, L.L.C., a Delaware limited liability company (the “Company”), Global Cash Access Finance Corporation, a Delaware corporation (“Finance Corp.” and, together with the Company, the “Co-Obligors”), the Subsidiary Guarantors (as defined below) and The Bank of New York, a New York banking corporation, as Trustee.
April 3rd, 2017 · Common Contracts · 467 similar Syneron Medical Ltd. – AGREEMENT AND PLAN OF MERGER BY AND AMONG LUPERT LTD., RENDEL AMARE LTD., AND SYNERON MEDICAL LTD. DATED AS OF APRIL 2, 2017 This AGREEMENT AND PLAN OF MERGER, dated as of April 2, 2017 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is entered into by and among Lupert Ltd., a company incorporated under the Laws of the State of Israel (“Parent”), Rendel Amare Ltd., a company incorporated under the Laws of the State of Israel and a wholly owned Subsidiary of Parent (“Merger Sub”), and Syneron Medical Ltd., a company incorporated under the Laws of the State of Israel (the “Company”).
This AGREEMENT AND PLAN OF MERGER, dated as of April 2, 2017 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), is entered into by and among Lupert Ltd., a company incorporated under the Laws of the State of Israel (“Parent”), Rendel Amare Ltd., a company incorporated under the Laws of the State of Israel and a wholly owned Subsidiary of Parent (“Merger Sub”), and Syneron Medical Ltd., a company incorporated under the Laws of the State of Israel (the “Company”).
January 29th, 1998 · Common Contracts · 449 similar Amnex Inc – Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of December 24, 1997, by and among AMNEX, Inc., a New York corporation, with its headquarters located at 6 Nevada Drive, Lake Success, New York 11042...
May 24th, 2006 · Common Contracts · 426 similar Global Cash Access Holdings, Inc. – Global Cash Access Holdings, Inc. Common Stock, par value $0.001 Underwriting Agreement Certain stockholders named in Schedule II hereto (collectively, the “Selling Stockholders”) of Global Cash Access Holdings, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 10,400,000 shares of Common Stock, par value $0.001 per share, of the Company (“Stock”), (the “Firm Shares”). The Selling Stockholders also propose, subject to the terms and conditions stated herein, at the election of the Underwriters, to sell to the Underwriters up to 1,560,000 additional shares of Stock (the “Optional Shares”). The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares.”
Certain stockholders named in Schedule II hereto (collectively, the “Selling Stockholders”) of Global Cash Access Holdings, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 10,400,000 shares of Common Stock, par value $0.001 per share, of the Company (“Stock”), (the “Firm Shares”). The Selling Stockholders also propose, subject to the terms and conditions stated herein, at the election of the Underwriters, to sell to the Underwriters up to 1,560,000 additional shares of Stock (the “Optional Shares”). The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares.”
November 6th, 2019 · Common Contracts · 409 similar Armada Hoffler Properties, Inc. – INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (“Agreement”) is made and entered into as of the day of , 20__, by and between Armada Hoffler Properties, Inc., a Maryland corporation (the “Company”), and (“Indemnitee”). See Schedule A for a list of officers and directors who have entered into this Indemnification Agreement with the Company.
THIS INDEMNIFICATION AGREEMENT (“Agreement”) is made and entered into as of the day of , 20__, by and between Armada Hoffler Properties, Inc., a Maryland corporation (the “Company”), and (“Indemnitee”). See Schedule A for a list of officers and directors who have entered into this Indemnification Agreement with the Company.
February 12th, 2021 · Common Contracts · 374 similar Cassava Sciences Inc – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 10, 2021, between Cassava Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of February 10, 2021, between Cassava Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
May 30th, 2014 · Common Contracts · 374 similar BioLineRx Ltd. – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of May 28, 2014, by and between BIOLINERX, LTD., a State of Israel corporation, (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of May 28, 2014, by and between BIOLINERX, LTD., a State of Israel corporation, (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").
December 20th, 2019 · Common Contracts · 370 similar Ekso Bionics Holdings, Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 18, 2019, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of December 18, 2019, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
March 4th, 2021 · Common Contracts · 368 similar Anzu Special Acquisition Corp I – INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as __, 2021 by and between Anzu Special Acquisition Corp I, a Delaware corporation (the “Company”), and [D&O] (“Indemnitee”).
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as __, 2021 by and between Anzu Special Acquisition Corp I, a Delaware corporation (the “Company”), and [D&O] (“Indemnitee”).
September 24th, 2007 · Common Contracts · 362 similar Inter-Atlantic Financial, Inc. – Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT is made as of [____________] [____], 2007, between Inter-Atlantic Financial, Inc., a Delaware corporation, with offices at 400 Madison Avenue, New York, NY 10017 (the "COMPANY"), and American Stock...
November 2nd, 2020 · Common Contracts · 337 similar Allakos Inc. – Underwriting Agreement Allakos Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,048,781 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 457,317 additional shares (the “Optional Shares”) of the Common Stock, par value $0.001 per share (“Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
Allakos Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,048,781 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 457,317 additional shares (the “Optional Shares”) of the Common Stock, par value $0.001 per share (“Stock”) of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
February 9th, 2018 · Common Contracts · 317 similar Pain Therapeutics Inc – Capital on Demand™ Sales Agreement PAIN THERAPEUTICS, INC. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JONESTRADING INSTITUTIONAL SERVICES LLC (the “Agent”), as follows:
PAIN THERAPEUTICS, INC. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JONESTRADING INSTITUTIONAL SERVICES LLC (the “Agent”), as follows:
December 20th, 2016 · Common Contracts · 314 similar Boyd Acquisition I, LLC – BOYD GAMING CORPORATION AND THE GUARANTORS NAMED HEREIN 6.375% SENIOR NOTES DUE 2026 INDENTURE Dated as of March 28, 2016 WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee INDENTURE dated as of March 28, 2016 by and among Boyd Gaming Corporation, a Nevada corporation (including any and all successors thereto, the “Company”), the Guarantors (as defined herein) and Wilmington Trust, National Association, as trustee (the “Trustee”).
INDENTURE dated as of March 28, 2016 by and among Boyd Gaming Corporation, a Nevada corporation (including any and all successors thereto, the “Company”), the Guarantors (as defined herein) and Wilmington Trust, National Association, as trustee (the “Trustee”).
March 29th, 2016 · Common Contracts · 313 similar Boyd Gaming Corp – REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 28, 2016 by and among Boyd Gaming Corporation, a Nevada corporation (the “Company”), the guarantors named in Schedule A hereto and any subsidiary of the Company formed or acquired after the Closing Date that executes an additional guarantee in accordance with the terms of the Indenture (as defined below), and their respective successors and assigns (collectively, the “Guarantors”), and Deutsche Bank Securities Inc., on behalf of itself and as representative (the “Representative”) of the several initial purchasers listed on Schedule A to the Purchase Agreement (as defined below) (collectively, the “Initial Purchasers”), who have agreed to purchase the Company’s 6.375% Senior Notes due 2026 (the “Initial Notes”) fully and unconditionally guaranteed by the Guarantors (the “Guarantees”) pursuant to the Purchase Agreement (as defined below). The Initial Notes and the Guarantees attached thereto are he
This Registration Rights Agreement (this “Agreement”) is made and entered into as of March 28, 2016 by and among Boyd Gaming Corporation, a Nevada corporation (the “Company”), the guarantors named in Schedule A hereto and any subsidiary of the Company formed or acquired after the Closing Date that executes an additional guarantee in accordance with the terms of the Indenture (as defined below), and their respective successors and assigns (collectively, the “Guarantors”), and Deutsche Bank Securities Inc., on behalf of itself and as representative (the “Representative”) of the several initial purchasers listed on Schedule A to the Purchase Agreement (as defined below) (collectively, the “Initial Purchasers”), who have agreed to purchase the Company’s 6.375% Senior Notes due 2026 (the “Initial Notes”) fully and unconditionally guaranteed by the Guarantors (the “Guarantees”) pursuant to the Purchase Agreement (as defined below). The Initial Notes and the Guarantees attached thereto are he
March 19th, 2010 · Common Contracts · 303 similar NovaRay Medical, Inc. – Contract THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR THE ISSUER SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR THE ISSUER SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.
October 5th, 2021 · Common Contracts · 290 similar Velo3D, Inc. – THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of May 14, 2021 (the “Effective Date”), between SILICON VALLEY BANK, a California corporation (“Bank”), and VELO3D, INC., a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
THIS THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of May 14, 2021 (the “Effective Date”), between SILICON VALLEY BANK, a California corporation (“Bank”), and VELO3D, INC., a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
March 7th, 2007 · Common Contracts · 264 similar Clearwire Corp – Exhibit 1.1 CLEARWIRE CORPORATION (A DELAWARE CORPORATION) __ SHARES OF CLASS A COMMON STOCK PURCHASE AGREEMENT Dated: __, 2007 CLEARWIRE CORPORATION (a Delaware corporation) __ Shares of Class A Common Stock (Par Value $0.0001 Per Share) PURCHASE AGREEMENT
July 21st, 2021 · Common Contracts · 255 similar RE/MAX Holdings, Inc. – SECOND AMENDED AND RESTATED CREDIT AGREEMENT among RMCO, LLC, RE/MAX, LLC, as Borrower, The Several Lenders from Time to Time Parties Hereto, and JPMorgan Chase Bank, N.A., as Administrative Agent Dated as of July 21, 2021 JPMorgan Chase Bank, N.A. as... SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”), dated as of July 21, 2021, among RMCO, LLC, a Delaware limited liability company (“Parent”), RE/MAX, LLC (f/k/a RE/MAX International, LLC), a Delaware limited liability company (the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (the “Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent.
SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”), dated as of July 21, 2021, among RMCO, LLC, a Delaware limited liability company (“Parent”), RE/MAX, LLC (f/k/a RE/MAX International, LLC), a Delaware limited liability company (the “Borrower”), the several banks and other financial institutions or entities from time to time parties to this Agreement (the “Lenders”) and JPMorgan Chase Bank, N.A., as administrative agent.
March 27th, 2020 · Common Contracts · 253 similar Cassava Sciences Inc – Sales Agreement Cassava Sciences, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:
Cassava Sciences, Inc. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC (the “Agent”), as follows:
July 3rd, 2006 · Common Contracts · 245 similar Plum Creek Timber Co Inc – CREDIT AGREEMENT Dated as of June 29, 2006 among PLUM CREEK TIMBERLANDS, L.P., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, SUNTRUST BANK, as Syndication Agent, THE BANK OF TOKYO- MITSUBISHI UFJ,...
November 6th, 2019 · Common Contracts · 223 similar Red Cedar Fund Trust – CUSTODY AGREEMENT THIS AGREEMENT is made and entered into as of the last date on the signature page, by and between RED CEDAR FUND TRUST, a Delaware statutory trust, (the “Trust”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America with its principal place of business at Minneapolis, Minnesota (the “Custodian”).
THIS AGREEMENT is made and entered into as of the last date on the signature page, by and between RED CEDAR FUND TRUST, a Delaware statutory trust, (the “Trust”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association organized and existing under the laws of the United States of America with its principal place of business at Minneapolis, Minnesota (the “Custodian”).
April 18th, 2018 · Common Contracts · 215 similar Marrone Bio Innovations Inc – MARRONE BIO INNOVATIONS, inc. COMMON STOCK UNDERWRITING AGREEMENT Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule VI hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 7,275,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, upon the terms and conditions stated herein, up to 1,091,250 additional shares (the “Additional Shares”) of Common Stock, $0.00001 par value per share (the “Common Stock”), of the Company (the Firm Shares and the Additional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Securities”).
Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule VI hereto (the “Underwriters”), for whom National Securities Corporation is acting as representative (the “Representative”), an aggregate of 7,275,000 authorized but unissued shares (the “Firm Shares”) and, at the election of the Underwriters, upon the terms and conditions stated herein, up to 1,091,250 additional shares (the “Additional Shares”) of Common Stock, $0.00001 par value per share (the “Common Stock”), of the Company (the Firm Shares and the Additional Shares that the Underwriters elect to purchase pursuant to Section 3 hereof being collectively called the “Securities”).
August 6th, 2014 · Common Contracts · 208 similar KBS Strategic Opportunity REIT, Inc. – LOAN AGREEMENT between 110 WILLIAM, LLC, as Borrower and UBS REAL ESTATE SECURITIES INC., as Lender Dated as of June 11, 2012 THIS LOAN AGREEMENT, dated as of June 11, 2012 (as amended, restated, replaced, supplemented or otherwise modified from time to time, this “Agreement”), between UBS REAL ESTATE SECURITIES INC., a Delaware corporation, having an address at 1285 Avenue of the Americas, New York, New York 10019 (together with its successors and assigns, collectively, “Lender”), and 100 WILLIAM, LLC, a Delaware limited liability company having an address at c/o Swig Equities, LLC, 110 William Street, 1st Floor, New York, New York 10038 (together with its permitted successors and assigns, collectively, “Borrower”).
THIS LOAN AGREEMENT, dated as of June 11, 2012 (as amended, restated, replaced, supplemented or otherwise modified from time to time, this “Agreement”), between UBS REAL ESTATE SECURITIES INC., a Delaware corporation, having an address at 1285 Avenue of the Americas, New York, New York 10019 (together with its successors and assigns, collectively, “Lender”), and 100 WILLIAM, LLC, a Delaware limited liability company having an address at c/o Swig Equities, LLC, 110 William Street, 1st Floor, New York, New York 10038 (together with its permitted successors and assigns, collectively, “Borrower”).
March 4th, 2010 · Common Contracts · 202 similar Mindspeed Technologies, Inc – Mindspeed Technologies, Inc. 2,524,138 Shares Common Stock ($0.01 par value) Underwriting Agreement Thomas Weisel Partners LLC As Representative of the Several Underwriters One Montgomery Street Suite 3700 San Francisco, California 94104
Thomas Weisel Partners LLC As Representative of the Several Underwriters One Montgomery Street Suite 3700 San Francisco, California 94104